Recent Insider Transactions - Aardvark Therapeutics (NASDAQ: AARD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ AARD Aardvark Therapeutics

Lee Tien-Li / director, 10 percent owner, officer: Chief Executive Officer

06/11/2025

Buy

$11.29

549,534

$6.204M

549,534

NASDAQ AARD Aardvark Therapeutics

Chi Jeffrey / director

06/11/2025

Buy

$11.29

61,017

$689K

61,017

NASDAQ AARD Aardvark Therapeutics

Jaiman Manasi / officer: Chief Medical Officer

06/11/2025

Buy

$11.29

126,999

$1.434M

126,999

NASDAQ AARD Aardvark Therapeutics

Baynes Roy D. / director

06/11/2025

Buy

$11.29

30,508

$344K

30,508

NASDAQ AARD Aardvark Therapeutics

Tong Victor Edward Jr / director

06/11/2025

Buy

$11.29

61,017

$689K

61,017

NASDAQ AARD Aardvark Therapeutics

Sun Nelson / officer: Chief Financial Officer

06/11/2025

Buy

$11.29

209,826

$2.369M

209,826

NASDAQ AARD Aardvark Therapeutics

Jones Bryan / officer: Chief Operating Officer

06/11/2025

Buy

$11.29

122,033

$1.378M

122,033

NASDAQ AARD Aardvark Therapeutics

Graf Susan E / director

06/11/2025

Buy

$11.29

30,508

$344K

30,508